Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75/Share to Acquire All Outstanding Shares of Sagent Pharmaceuticals,
Charles Gross